Open enrollment loses employees at the 200-page SPD. Benefits veteran Brandan Bruce shares how Help Me Choose Benefits gives employees simple, personalized guidance on what to enroll in and what to skip, and employers can launch it in days.

In This Episode

• Brandan's path from benefits admin and enrollment tech to Voya and Prudential
• A no-login, no-app tool that recommends products based on family, finances, and health
• Engagement tips: QR codes in enrollment materials plus multiple entry points
• Right-sized advice, so employees see goals they can actually reach
• AI that explains the "why" and translates into other languages

Key Insights

• Education without guidance leaves employees guessing
• Less friction (no login, no app) means more usage
• Recommendations must feel achievable, or all advice gets ignored
• Plain-language explanations of products like hospital indemnity drive better decisions

Who It's For: Employers, HR leaders, and brokers heading into open enrollment.

About Brandan Bruce:

Brandan Bruce is a lifelong employee benefits and insurtech entrepreneur with more than 25 years of experience across nearly every side of the group insurance industry. His career includes more than a decade in benefit administration and outsourcing with Mercer and Businessolver, followed by leadership roles on the carrier side with Voya and Prudential.
Brandan has founded and led three insurtech companies—Advice2Pay, T2B Solutions, Inc., and Help Me Choose Benefits (HMCB)—focused on solving complex industry challenges through technology. Today, he leads HMCB, an AI-powered benefits guidance platform that simplifies benefits and helps employees understand why—or why not—a benefit makes sense for them.
Outside of work, Brandan enjoys spending time at the Lake of the Ozarks with his wife Pamela, their family and grandkids, friends, and dogs. He is also an accomplished woodworker whose creations can be found in all 50 states.

Resources:

Connect with Brandan Bruce via LinkedIn: https://www.linkedin.com/in/brandan-bruce-73211a6/

Email: brandan@helpmechoosebenefits.com

Questions, topic ideas, or guest suggestions? Reach out: hello@alignco.life

Direct contracting stalls when nobody can move the money. Cory Morin explains how BenjiCard's pre-funded virtual cards pay providers at point of service, save plans money, and cut member costs.

In This Episode:

• Cory's path from insurance sales to fintech
• BenjiCard: pre-funded virtual Visa cards for TPAs, health plans, cost containment partners
• Virtual-only cards via Apple Pay/Google Pay; no physical cards
• Guardrails: U.S.-only, healthcare merchant codes, spending caps, provider locking
• Tier-zero/tier-one use case: waived member cost for pre-negotiated providers
• Next up: combining member cost-share and plan payment into one transaction
• Mostly TPA/health plan distribution, some direct-to-employer

Key Insights:

• Payment mechanics, not the contract, are the real bottleneck
• Prompt payment aligns providers, plans, and members
• Guardrails (not trust) make member-held plan dollars safe
• HSA/HDHP rules mean member cost-share isn't going away — one combined payment is next
• Fewer layers (direct-to-employer) beats the standard TPA chain

Who It's For: Brokers/consultants on direct contracting; HR/CFOs funding cost containment; TPAs, health plans, and cost containment companies.

About Cory Morin:

Cory Morin is the CEO and Founder of Benji Card, a healthcare payments platform built to make paying for care as simple as it should be. Based in Saratoga Springs, Utah, Cory started Benji Card to create alignment among the stakeholders in the healthcare transaction through the use of pre-funded virtual payment cards.

Before founding Benji Card, Cory spent years as a licensed insurance advisor, selling property & casualty insurance, small group health plans, and payroll services. That hands-on experience gave him a front-row seat to how businesses actually manage risk, benefits, and cash flow.

Cory holds a bachelor's degree in Entrepreneurship from Brigham Young University and a Master's in Business Creation from the University of Utah, pairing formal training in building companies with real-world sales and advisory experience. Today, he leads Benji Card's mission to give health shares, TPAs, health plans, cost containment solutions, and other healthcare organizations more control, transparency, and simplicity over every healthcare dollar spent one payment at a time.

Resources:

Connect with Cory via LinkedIn: https://www.linkedin.com/in/corymorin/

Email: cory@benjicard.com

Questions, topic ideas, or guest suggestions? Reach out: hello@alignco.life

Dr. Andrew White talks with Trey Hinson, a 26-year self-funded insurance veteran, about why stop loss carriers and DPCs (direct primary care) keep talking past each other — even though their interests are actually aligned. The takeaway: the disconnect isn't a data problem, it's an engagement problem.

In This Episode

Trey's path from Blue Cross Blue Shield to advising 91 TPAs and 150+ point solutions. Why stop loss carriers ask for detailed data — and why it's about shared risk, not distrust. The two metrics that actually matter to a stop loss carrier: engagement and medical trend. How to approach stop loss the right way, through the broker, TPA, and carrier.

Key Insights

Employers and stop loss carriers are the two parties with real financial risk in a self-funded plan, which is why data-sharing matters so much to carriers. Point solutions need engagement on two fronts: with their own patient population, and with their TPA/stop loss partners. Stop loss carriers care most about engagement rates and multi-year medical trend, not feature lists. TPAs act as the aggregation layer that turns fragmented vendor data into something a stop loss carrier can use.

Who This Episode Is For

DPC providers and point-solution operators, brokers and TPAs, and employers running or considering self-funded health plans.

About Trey Hinson:

Trey Hinson is the founder of Goliath Sales Strategies, LLC, and a 25-year veteran of the health insurance industry. He has built and led revenue teams across fully insured, government program, and self-funded markets, advising payers, TPAs, brokers, and benefits technology vendors. A PAHM-certified executive, Trey speaks candidly about what it takes to grow sales teams CEOs trust, build pipelines that don't lie, and become the name buyers remember in a crowded healthcare benefits market.

Resources & Links

Goliath Sales Strategies: https://www.goliathsalesstrategies.com/

LinkedIn: Connect with Trey Hinson: https://www.linkedin.com/in/treyhinson/

Questions, topic ideas, or guest suggestions? Reach out: hello@alignco.life

Most employers treat metabolic risk as a chemistry problem.

They track A1C. They monitor triglycerides. They debate GLP-1 coverage. They review pharmacy trend lines. And many of those interventions “work.” Weight drops. Labs improve. Claims stabilize.

But almost no one asks the harder question:

What happens when the intervention stops?

In this episode of Healthy Business Matters, Dr. Andrew White argues that metabolic dysfunction doesn’t begin with A1C — it begins when movement becomes expensive.

When bending hurts.

When knees swell.

When sleep is disrupted by pain.

When daily activity quietly declines.

Because insulin sensitivity isn’t primarily a lab issue. It’s a muscle issue.

Muscle is the largest site of glucose disposal in the body. When movement capacity erodes, metabolic stability follows.

Here’s the problem: movement capacity doesn’t show up on your dashboard. It doesn’t trigger a large claim. It doesn’t sit neatly inside a CPT code. It doesn’t get flagged in stop-loss reporting. It generates a pathway, not an event.

And employers manage events — not pathways.

In This Episode, You’ll Learn:

Why weight loss without movement capacity is fragile

How appetite suppression differs from metabolic strengthening

Why muscle mass is metabolic infrastructure

How mechanical inflammation drives biochemical instability

Why most wellness programs measure activity instead of tolerance

The difference between risk management and risk stabilization

Why short-term optics often undermine long-term durability

The Core Shift

Most metabolic strategies reduce load. Very few build structure.

Reducing load — through appetite suppression, medication, or calorie restriction — can improve numbers. Building structure — through movement tolerance, muscle preservation, and mechanical stability — improves durability.

Those are not the same outcome.

If muscle declines while weight declines, you may be improving biomarkers while weakening infrastructure. If pain persists while labs improve, fragility remains. If risk rebounds when the intervention stops, it was never a strategy — it was a subsidy.

The 4-Question Durability Framework

Before approving or expanding any metabolic or MSK initiative, run it through four filters:

Does this increase daily movement tolerance?

Not participation. Not logins. Not steps. Does the employee become more capable of bending, lifting, rotating, training, and recovering without friction?

Does this preserve or build muscle?

Muscle is metabolic infrastructure. Are you strengthening the engine — or simply suppressing the load?

Does this reduce mechanical inflammatory input?

Inflammation is not only dietary; it’s mechanical. Are joint instability and movement dysfunction being addressed?

When the intervention stops, what remains?

Is the employee stronger and more stable — or back at baseline? If risk rebounds when the intervention ends, you didn’t fix it. You financed it.

Who This Episode Is For

Progressive brokers tired of buying short-term optics

CFOs who care about durability, not dashboards

HR leaders balancing empathy and budget

Employers navigating GLP-1 expansion decisions

Anyone designing a metabolic strategy that must last beyond a single plan year

Healthy Business Matters is built for operators who make real decisions.

If this episode sharpened your thinking, share it with a broker, CFO, or HR leader who needs a clearer framework.

Follow and subscribe so you don’t miss future episodes.

If you’re wrestling with a question inside your own health plan, reach out directly at hello@alignco.life

Clear thinking. Better decisions. Healthier businesses.

GLP-1s are powerful.

They reduce appetite.

They lower A1C.

They drive meaningful weight loss.

For many patients, they are clinically appropriate and life-changing.

What’s controversial isn’t the drug.

It’s how employers are deploying it.

In too many health plans, GLP-1s are being used as the metabolic strategy instead of as a tool inside one. And those are not the same thing.

In this episode, Dr. Andrew White breaks down why weight loss alone does not equal metabolic durability and why employers who ignore sequencing, movement capacity, and off-ramps may be increasing long-term pharmacy exposure instead of reducing risk.

If you’re a CFO, broker, HR leader, or operator evaluating GLP-1 coverage, this episode gives you a practical framework you can use in your next renewal meeting.

What You’ll Learn

• Why GLP-1s reduce calories but don’t automatically restore movement capacity
• The difference between weight loss and metabolic resilience
• Why skeletal muscle is the real metabolic insurance policy
• The five-step sequence required for a true employer metabolic strategy
• Why most GLP-1 vendors avoid discussing discontinuation
• The blind spot almost no GLP-1 programs track: strength and muscle preservation
• Five hard questions every CFO should ask before approving coverage

The 5-Step Metabolic Strategy Framework

1. Remove inhibitors of movement
2. Restore movement capacity
3. Improve insulin sensitivity intentionally
4. Define the pharmacology off-ramp before starting
5. Reduce long-term pharmacy dependency

Because if the drug stops and the risk returns, you didn’t change the pathway you suppressed a symptom

Who This Episode Is For

• Self-funded employers
• CFOs evaluating pharmacy exposure
• Brokers navigating competitive GLP-1 pressure
• HR leaders caught between recruitment demands and long-term cost control

If you care about reducing risk instead of managing optics, this episode is for you.

About the Host

Dr. Andrew White is the Founder and CEO of AlignWell, a national MSK and metabolic risk management company working with self-funded employers to reduce long-term claims exposure by changing where care starts and how risk is sequenced.

If this episode sharpened your thinking:

Share it with a broker or CFO who needs a clearer framework

Follow/subscribe on Apple or Spotify so you don’t miss future episodes

Send topic ideas or renewal questions to hello@alignco.life

Healthy Business Matters is built for people who make real decisions.

Clear thinking. Better incentives. Healthier businesses.

Most employers believe they have separate healthcare problems:

• An MSK problem
• An obesity problem
• A GLP-1 problem
• A pharmacy trend problem

They don’t.

They have a pathway problem.

In this episode, we connect the dots most benefit strategies keep siloed and make the case that musculoskeletal pain is often the front door to long-term metabolic dysfunction.

When something hurts, people move less.

When movement drops, insulin sensitivity declines.

When metabolism shifts, risk compounds.

Months or years later, that shows up in a completely different budget category.

By the time you’re debating GLP-1 spend, the pathway was already set.

GLP-1 didn’t create your metabolic risk.

It revealed it.

In This Episode:

• Why MSK is often the earliest visible signal of metabolic drift
• The physiological cascade from chronic pain → reduced movement → insulin resistance
• How untreated MSK quietly compounds pharmacy and catastrophic exposure
• Why most employers miss the connection (and why it’s structural, not careless)
• Where GLP-1 actually fits inside a coordinated risk strategy
• A 3-question framework to evaluate any MSK or metabolic initiative

Key Insight

Healthcare reporting tells you where you spent money.

It rarely tells you where risk began.

If you treat MSK as an isolated injury category, you’ll always be managing metabolic risk later.

The Framework

Before approving any MSK or GLP-1 strategy, ask:

1. Does this change daily movement capacity?
2. Does it improve metabolic stability?
3. Does it alter long-term catastrophic risk — not just this year’s spend?

If the answer is no to any one of those, you’re managing a category not engineering trajectory.

If you treat the Trojan horse as a back problem, you’ll miss the army inside it.

Healthy Business Matters is a thinking platform for progressive brokers, CFOs, and operators who want to move beyond managing healthcare spend; and start engineering risk.

Questions, topic ideas, or guest suggestions?

Reach out: hello@alignco.life

Where Care Starts Is Where Costs Are Decided

Most healthcare costs are locked in long before a diagnosis code ever hits a claim. By the time something shows up in reporting, the damage is already done; not because of fraud, bad doctors, or the wrong vendor, but because of where care started.

In this episode of Healthy Business Matters, Dr. Andrew White breaks down a simple but uncomfortable truth:

Healthcare costs are driven by pathways, not prices. And if you do not intentionally design the front door to care, the system will design it for you.

What This Episode Covers

• Why outcomes are decided at the first decision moment, not the back end of claims
• A real-world MSK example showing how the same injury produces radically different cost trajectories
• How ER, urgent care, and specialist-first pathways quietly create predictable, compounding spend
• Why most “proactive” health initiatives stay reactive despite high engagement
• The difference between managing spend and actually managing risk

The Three MSK Pathways Explained

1. Default System Path

• Pain → ER or urgent care
• Imaging → referrals → injections → surgery discussions
• $8K–$15K episodes that routinely balloon into $30K–$100K+ claims

2. Early Conservative Triage

• Pain → MSK-literate first contact
• Conservative care first, escalation when appropriate
• Imaging used intentionally, not reflexively
• Same injury, radically lower cost trajectory

3. Pre-Claim Interception

• Onsite screening identifies issues before employees seek care
• Movement patterns corrected, loads managed early
• No ER visit, no claim, no cascade
• Demand never forms in the wrong system

The Front Door Test Before buying any health initiative or vendor, ask:

1. Does this change where first contact happens?

If it does not influence the first decision moment, it does not change the pathway.

2. Does it reduce friction at the moment of need?

Is it easier than the ER? Faster than urgent care? Clearer than Google?

3. Does it redirect demand before claims crystallize?

If it only manages claims after imaging and referrals begin, risk control is already gone. If a program cannot answer all three clearly, it is a support program, not a cost-control strategy.

Key Takeaway

Employers are not overspending because care is expensive. They are overspending because demand is being formed too late and in the wrong place.

You cannot manage that downstream.

You have to redesign where care begins.

Challenge for Employers and Brokers

Audit your health strategy by entry point, not by category:

• Where does MSK care start?
• Where does metabolic care start?
• Where does mental health care start?
• Where does primary care start?

Wherever care starts is where your cost curve is being set.

If this episode sharpened your thinking, follow the show and share it with someone responsible for managing risk, not decorating dashboards.

New episodes drop every Tuesday.